GlobalData on MSN2d
Health Canada approves MedMira’s rapid test for HIV and syphilis
The test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, ...
Pharmabiz2d
Health Canada approves MedMira’s Multiplo Rapid TP/HIV test for Syphilis and HIV
Health Canada approves MedMira’s Multiplo Rapid TP/HIV test for Syphilis and HIV: Halifax, Canada Friday, December 27, 2024, 10:00 Hrs [IST] MedMira Inc. (MedMira), a leading de ...
Morningstar4d
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ...
MedMira Gains Health Canada Approval for Rapid Test
Medmira (TSE:MIR) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street analysts, ...
Finanznachrichten4d
MedMira, Inc.: MedMira receives Health Canada approval for its Multiplo Rapid Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ...
Nasdaq4d
MedMira Gains Health Canada Approval for Rapid Test
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter MedMira Inc. has received approval from Health Canada for its ...